Abstract
The illicit synthesis and use of a meperidine analogue containing a side reaction product, l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP), led to the discovery that this contaminant is a neurotoxin which produces in some animals, as well as in humans, a motor disorder which closely resembles Parkinson’s Disease (Davis, et al., 1979; Langston, et al., 1983). This discovery has stimulated considerable research in efforts to determine the areas of brain which are involved, the attendant biochemical changes, the mechanisms of toxicity, and the usefulness of the toxin-induced motor disorder as an animal model with which to gain further insight into the pathogenesis and treatment of Parkinson’s Disease. It is the purpose of this presentation to recount the history of this discovery, to review our present knowledge of MPTP- induced motor disorders and to examine the implications for understanding spontaneously occurring Parkinson’s Disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Birkmayer, W., Knoll,J., Riederer,P., and Youdim, M.B.H., 1983, (-)- Deprenyl leads to prolongation of 1-dopa efficacy in parkinson’s disease, Mod. Probl. Pharmacopsychiat., 19: 170–176.
Burns, R.S., Chiueh, C.C., Markey, S.P., Ebert, M.H., Jacobowitz, D.M., and Kopin, I.J., 1983, A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-l,2,3,6-tetrahydropyridine, Proc Natl Acad Sci USA, 80: 4546–50.
Burns, R.S., Chiueh, C.C., Markey, S.P., Ebert, M.H., Jacobowitz, D.M., and Kopin, I.J., 1983, A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-l,2,3,6-tetrahydropyridine, Proc Natl Acad Sci USA, 80: 4546–50.
Burns, R.S., Chiueh, C.C., Markey, S.P., Ebert, M.H., Jacobowitz, D.M., and Kopin, I.J., 1983, A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-l,2,3,6-tetrahydropyridine, Proc Natl Acad Sci USA, 80: 4546–50.
Bus, J.S., Cogen, S., Olgaard, M., and Gibson, J.E., 1976, A mechanism of paraquat toxicity in mice and rats. Toxicol. Appl. Pharmacol., 35: 501–513.
Chiba, K., Trevor, A., Castagnoli, N.,Jr., 1984, Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase, Biochem. Biophys. Res. Commun, 120: 574–578.
Chiueh, C.C., Markey, S.P., Burns, R.S., Johannessen, J.N., Jacobowitz, D.M., and Kopin, I.J., 1984a, Neurochemical and behavioral effects of 1- methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP) in rat, guinea pig, and monkey PsychoPharmacol Bull, 20 (3): 548–553.
Chiueh, C.C., Markey, S.P., Burns, R.S., Johannessen, J.N., Pert, A., and Kopin, I.J., 1984b, Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-l,2,3,6-tetrahydro- pyridine in the rat, Eur. J. Pharmacol., 20: 100 (2): 189–194.
Chiueh, C.C., Burns, R.S., Markey, S.P., Jacobowitz, D.M. and Kopin, I.J., 1985a, Primate Model of parkinsonism: Selective lesion of nigrostriatal neurons by l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys. Life Sci., 36: 213–218.
Chiueh, C.C., Johannessen, J.N., Chesselet, M.F., and Markey, S.P., 1985b, Neurotoxic mechanism of l-methyl-4-pheny1-1,2,3,6-tetrahydropyridine (MPTP) and its oxidative metabolites in the nigrostriatal system of C57BL6 mice., Fed. Proc., 44: 893.
Cohen, G., 1984, Oxy-radical toxicity in catecholamine neurons, Neuro- toxicology, 5 (1): 77–82.
Davis, G.C., Williams, A.C., Markey, S.P., Ebert, M.H., Caine, E.D., Beichert, C.M., and Kopin, I.J., 1979, Chronic parkinsonism secondary to intravenous injection of meperidine analogues, Psychiatry. Res., 1: 249–254.
Del Zompo, M., Bocchetta, A., Piccardi, M.P., Pintus, S., Corsini, G.U., 1984, Inhibition of 3H MPTP binding to rat brain by pargyline, Biochem. Pharmacol., 33 (24): 4105–4107.
Donaldson, J., and LaBella, F.S., 1984, The effects of manganese on the cholinergic receptor in vivo and in vitro may be mediated through modulation of free radicals, Neurotoxicology, 5 (1): 105–112.
Enz, A., Hefti, F., and Frick, W., 1984, Acute administration of 1- methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP) reduces dopamine and serotonin but accelerates norepinephrine metabolism in the rat brain. Effect of chronic pretreatment with MPTP, Eur. J. Pharmacol., 101 (1-2): 37–44.
Foster, R.H.K., and Carmen, A.J., 1947, Studies in analgesia: piperidine derivatives with morphine-like activity, J. Pharm. Exp. Ther., 91: 195–209.
Freeman, B.A., and Crapo, J.D., 1982, Biology of Disease: Free radicals and tissue injury, Lab. Invest., 47 (5): 412.
Fridovich, I., 1975, Superoxide Dismutases, Ann. Rev. Biochem., 44: 147–159.
Fuller, R.W., Hahn, R.A., Snoddy, H.D., and Wikel, J.H., 1984, Depletion of cardiac norepinephrine in rats and mice by 1-methyl-4-pheny1-1,2,3,6- tetrahydropyridine (MPTP), Biochem. Pharmacol., 33 (19): 2957–2960.
Graham, D.G., 1978, Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones, Mol. Pharmacol., 14: 633–634.
Graham, D.G., 1984, Catecholamine toxicity: A proposal for the molecular pathogenesis of manganese neurotoxicity and parkinson’s disease, Neurotoxicology, 5 (1): 83–96.
Hallman, H., Lange, J., Olson, L., Stromberg, I., and Jonsson, G., 1985, Neurochemical and histochemical characterization of neurotoxic effects of l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse, J. Neurochem., 44 (1): 117–127.
Hallman, H., Olson, L., and Jonsson, G., 1984, Neurotoxicity of the meperidine analogue N-methy1-4-pheny1-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse, Eur. J. Pharmacol., 97 (1- 2): 133–136.
Halliwell, B., 1984, Manganese ions, oxidation reactions and the superoxide radical, Neurotoxicology, 5 (1): 113–118.
Heikkila, R.E., Cabbat, F.S., Manzino, L., and Duvoisin, R.C., 1984a, Effects of l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine on negrostriatal dopamine in mice, Neuropharmacology, 23 (6): 711–713.
Heikkila, R.E., Hess, A., and Duvoisin, R.C., 1984b, Dopaminergic neurotoxicity of l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine in mice, Science, 224 (4656): 1451–1453.
Heikkila, R.E., Manzino, L., Cabbat, F.S., and Duvoisin, R.C., 1984c, Protection against the dopaminergic neurotoxicity of l-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors, Nature, 311 (5985): 467–469.
Jacobs, B.L., 1976, An animal behavior model for studying central serotonin synapses, Life Sci., 19: 777.
Javitch, J.A., and Snyder, S.H., 1985, Uptake of MPP+ by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP, Eur. J. Pharm., 106: 455–456.
Javitch, J.A., Uhl, G.R., and Snyder, S.H., 1984, Parkinsonism-inducing neurotoxin,N-methyl-4-phenyl-l,2,3,6-tetrahydropyridine: characterization and localization of receptor binding sites in rat and human brain, Proc Natl Acad Sci USA, 81 (14): 4591–4595.
Jenner, P., Rupniak, N.M., Rose, S., Kelly, E., Kilpatrick, G., Lees, A., and Marsden, C.D., 1984, l-methyl-4-phenyl-l,2,3,6-tetrahydro- pyridine-induced parkinsonism in the common marmoset, Neurosci. Lett., 50(1-3):85–90.
Johannesen, J.N., Chiueh, C.C., Burns, R.S., and Markey, S.P., 1985, Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects, Life Sci. 36: 219–224.
Johannessen, J.N., and Markey, S.P., 1984, Assessment of the opiate properties of two constituents of a toxic illicit drug mixture, Drug Alcohol. Depend., 13 (4): 367–374.
Langston, J.W., 1985, MPTP neurotoxicity: An overview and characterization of phases of toxicity, Life Sci., 36: 201–206.
Langston, J.W., Ballard, P., Tetrud, J.W., and Irwin, I., 1983, Chronic parkinsonism in humans due to a product of meperidine-analog synthesis, Science, 219 (4587): 979–980.
Langston, J.W., Forno, L.S., Rebert, C.S., and Irwin, I., 1984a, Selective nigral toxicity after systemic administration of l-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey, Brain Res., 292 (2): 390–394.
Langston, J.W., Irwin, I., Langston, E.B., and Forno, L.S., 1984b, 1- methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra, Neurosci. lett., 49(1):87–92.
Langston, J.W., Irwin, I., Langston, E.B., and Forno, L.S., 1984c, Pargyline prevents MPTP-induced parkinsonism in primates, Science, 225 (4669): 1480–1482.
Lyden, A., Bondesson, V., Larsson, B.S., and Lindquist, N.G., 1983, Melanin affinity of l-methyl-4-phenyl,l,2,3,6-tetrahydropyridine an inducer of chronic parkinsonism in humans, Acta Pharmacol, et. toxicol., 53: 429–432.
Markey, S.P., Johannsessen, J.N., Chiueh, C.C., Burns, R.S., and Herkenham, M.A., 1984, Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism, Eur. J. Pharmacol., 102 (2): 375–377.
Trush, M.A., Mimnaugh, E.G., and Gram, T.E., 1982, Activation of pharmacologic agents to radical intermediates: Implications for the role of free radicals in drug action and toxicity, Biochem. Pharmacol., 31: 3335–3346.
Van Woert, M.H., and Ambani, L.M., 1974, Biochemistry of neuromelanin, Adv. Neurology., 5: 215–223.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Kopin, I.J., Burns, S.R., Chiueh, C.C., Markey, S.P. (1986). MPTP-Induced Parkinsonian Syndromes in Humans and Animals. In: Fisher, A., Hanin, I., Lachman, C. (eds) Alzheimer’s and Parkinson’s Disease. Advances in Behavioral Biology, vol 29. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2179-8_59
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2179-8_59
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9283-8
Online ISBN: 978-1-4613-2179-8
eBook Packages: Springer Book Archive